This Article Full Text Full Text (PDF) All Versions of this Article: 46/2/249    most recent 01.HYP.0000172945.06681.a4v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khalil, R. A. Search for Related Content PubMed PubMed Citation Articles by Khalil, R. A. Related Collections Endothelium/vascular type/nitric oxide Other Vascular biology

(Hypertension. 2005;46:249.)
© 2005 American Heart Association, Inc.

Hypertension Highlights

Sex Hormones as Potential Modulators of Vascular Function in Hypertension

From the Division of Vascular Surgery, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.

Correspondence to Raouf A. Khalil, MD, PhD, Harvard Medical School, Brigham and Women’s Hospital, Vascular Surgery Research, NRB 654, 77 Ave Louis Pasteur, Boston, MA 02115. E-mail raouf_khalil{at}hms.harvard.edu

The greater incidence of hypertension in men and postmenopausal women compared with premenopausal women has suggested gender differences in vascular function. Vascular effects of the female sex hormones estrogen and progesterone and the male hormone testosterone have been described. Sex steroid receptors have been identified in vascular endothelium and smooth muscle. Interaction of sex hormones with cytosolic/nuclear receptors initiates long-term genomic effects that stimulate endothelial cell growth but inhibit smooth muscle proliferation. Activation of sex hormone receptors on the plasma membrane triggers nongenomic effects that stimulate endothelium-dependent vascular relaxation via NO–cGMP, prostacyclin–cAMP, and hyperpolarization pathways. Sex hormones also cause endothelium-independent inhibition of vascular smooth muscle contraction, [Ca²⁺]_i, and protein kinase C. These vasorelaxant/vasodilator effects suggested vascular benefits of hormone replacement therapy (HRT) during natural and surgically induced deficiencies of gonadal hormones. Although some clinical trials showed minimal benefits of HRT in postmenopausal hypertension, the lack of effect should not be generalized because it could be related to the type/dose of sex hormone, subjects’ age, and other cardiovascular conditions. The prospect of HRT relies on continued investigation of the molecular mechanisms underlying the vascular effects of sex hormones and identification of compounds that specifically target the vascular sex hormone receptors. Naturally occurring hormones and phytoestrogens may be more beneficial HRT than synthesized compounds. Also, the type/dose, time of initiation, and duration of HRT should be customized depending on the subject’s age and preexisting cardiovascular condition, and thereby enhance the outlook of sex hormones as potential modulators of vascular function in hypertension.

Key Words: estrogen • endothelium • nitric oxide • muscle, smooth, vascular • calcium

This article has been cited by other articles:

				K. Norris and A. R. Nissenson Race, Gender, and Socioeconomic Disparities in CKD in the United States J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1261 - 1270. [Abstract] [Full Text] [PDF]

				H. Mouridsen, A. Keshaviah, A. S. Coates, M. Rabaglio, M. Castiglione-Gertsch, Z. Sun, B. Thurlimann, L. Mauriac, J. F. Forbes, R. Paridaens, et al. Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial J. Clin. Oncol., December 20, 2007; 25(36): 5715 - 5722. [Abstract] [Full Text] [PDF]

				E. D. Szmuilowicz, G. K. Adler, V. Ricchiuti, P. N. Hopkins, and E. W. Seely Relationships between Endogenous Sex Hormone Concentrations and Vascular Function in Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4738 - 4741. [Abstract] [Full Text] [PDF]

				D. X. Zhang, K. M. Gauthier, J. R. Falck, A. Siddam, and W. B. Campbell Steroid-Producing Cells Regulate Arterial Tone of Adrenal Cortical Arteries Endocrinology, August 1, 2007; 148(8): 3569 - 3576. [Abstract] [Full Text] [PDF]

				K. Denton and C. Baylis Physiological and molecular mechanisms governing sexual dimorphism of kidney, cardiac, and vascular function Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R697 - R699. [Full Text] [PDF]

				L. J Pearson, C. Rait, M G. Nicholls, T. G Yandle, and J. J Evans Regulation of adrenomedullin release from human endothelial cells by sex steroids and angiotensin-II. J. Endocrinol., October 1, 2006; 191(1): 171 - 177. [Abstract] [Full Text] [PDF]

				N. Franceschini, J. W. MacCluer, H. H.H. Goring, S. A. Cole, K. M. Rose, L. Almasy, V. Diego, S. Laston, E. T. Lee, B. V. Howard, et al. A Quantitative Trait Loci-Specific Gene-by-Sex Interaction on Systolic Blood Pressure Among American Indians: The Strong Heart Family Study Hypertension, August 1, 2006; 48(2): 266 - 270. [Abstract] [Full Text] [PDF]

				I. H. Schulman, P. Aranda, L. Raij, M. Veronesi, F. J. Aranda, and R. Martin Surgical Menopause Increases Salt Sensitivity of Blood Pressure Hypertension, June 1, 2006; 47(6): 1168 - 1174. [Abstract] [Full Text] [PDF]

				C. Mineo and P. W. Shaul Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae Cardiovasc Res, April 1, 2006; 70(1): 31 - 41. [Abstract] [Full Text] [PDF]